Editas Medicine EDIT
NASDAQ EDIT
$2.63 +0.05 (+1.74%)
As of: Sep 30, 2026 · 11:43 AM EDT

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)

Updated

Editas Medicine (EDIT) reported Other Operating Expenses of $2,000 for Q4 2020, up 100.0% from $1,000 a year earlier.

Analysis

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020) Analysis & Trends

For FY2016, Editas Medicine posted Other Operating Expenses of $40.48 million.

  • The Q4 2020 figure ranks as the highest quarterly Other Operating Expenses since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Editas Medicine 234.09 Mn -477.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2,000.00
Dec 31, 2019 1,000.00
Dec 31, 2016 26.84 Mn
API Access

Editas Medicine Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=EDIT&period=max&api_key=YOUR_API_KEY